Follow-up analysis shows improvements in clinical outcomes for young adults with sickle cell disease, suggesting need for adult care capacity in Malawi.
Key Points
Overall, 94% of young adults with sickle cell disease in Malawi are alive and receiving care, emphasizing the success of hydroxyurea therapy.
Registered metrics include mean hemoglobin of 8.0 g/dL and 21% had received a blood transfusion during their treatment.
Analysis of electronic records from Kamuzu Central Hospital identified important trends in patient demographics and hospitalization rates.
Findings indicate critical implications for future sickle cell disease management, focusing on transitional support into adulthood.